Arcellx
http://arcellx.comWe are a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies.
... Read More
Country
United States
City
Redwood City
Headquarters
Redwood City, California
Industry
Biotechnology Research
Size
51 - 200
Specialties
biotechnology, car-t, cell therapy, multiple myeloma, oncology
Total Rounds
7
Last Round
Tue Nov 14 2023
Last Round Series
Post IPO equity
Last Round Raised
$ 200,000,000